Clostridium difficile is a significant source of infectious disease death in the United States, and C. difficile infection can be difficult to treat. Many researchers are focusing on new therapies for this major health problem, including clinical use of fecal microbiota transplantation. Dietary manipulations are another avenue of study. Researchers at the Stanford University School of Medicine recently published a paper in this vein entitled "Microbiota-accessible carbohydrates suppress Clostridium difficile infection in a murine model" in the journal Nature Microbiology.
Hryckowian et al. generated humanized microbiota mice by colonizing germ-free Swiss Webster mice from Taconic Biosciences with healthy human donor microbiota. In an antibiotic-induced C. difficile infection model, the humanized microbiota mice maintained on a diet containing microbiota-accessible carbohydrates (MACs) efficiently cleared the pathogen, whereas humanized microbiota mice maintained on a diet deficient in MACs had persistent infection for a prolonged period. Similar results were observed in conventional microbiota Swiss Webster and C57BL/6NTac mice as well as germ-free Swiss Webster mice which were associated with a conventional mouse gut flora1.
The researchers hypothesize that MACs may act in two ways to control C. difficile:
MACs may drive growth of gut bacteria which use MACs, suppressing C. difficile growth.
MAC metabolism produces short chain fatty acids, which also suppresses C. difficile.
As the authors write, this study "is part of a growing body of literature providing evidence that dietary manipulation of the metabolic networks of the intestinal tract is a powerful and underexplored way to influence gastrointestinal pathogens1."
1. Hryckowian, A. J.; Treuren, W. V.; Smits, S. A.; Davis, N. M.; Gardner, J. O.; Bouley, D. M.; Sonnenburg, J. L. Nature Microbiology. 2018.
We’re Here to Help
Experience & Expertise You Can Trust
Taconic Biosciences' model generation team has produced about 5,000 models in the last 15 years, developing a globally-recognized reputation for advancing the work of in vivo researchers. Our scientific program managers are here to help you navigate the complexities of model generation.